These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36402249)

  • 1. Dietary squalene supplementation decreases triglyceride species and modifies phospholipid lipidomic profile in the liver of a porcine model of non-alcoholic steatohepatitis.
    Herrera-Marcos LV; Martínez-Beamonte R; Arnal C; Barranquero C; Puente-Lanzarote JJ; Herrero-Continente T; Lou-Bonafonte JM; Gonzalo-Romeo G; Mocciaro G; Jenkins B; Surra JC; Rodríguez-Yoldi MJ; Burillo JC; Lasheras R; García-Gil A; Güemes A; Koulman A; Osada J
    J Nutr Biochem; 2023 Feb; 112():109207. PubMed ID: 36402249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic signatures discriminate subtle hepatic changes in the progression of porcine nonalcoholic steatohepatitis.
    Herrera-Marcos LV; Martínez-Beamonte R; Arnal C; Barranquero C; Puente-Lanzarote JJ; Lou-Bonafonte JM; Gonzalo-Romeo G; Mocciaro G; Jenkins B; Surra JC; Rodríguez-Yoldi MJ; Alastrué-Vera V; Letosa J; García-Gil A; Güemes A; Koulman A; Osada J
    Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G411-G425. PubMed ID: 38375587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially Expressed Genes in Response to a Squalene-Supplemented Diet Are Accurate Discriminants of Porcine Non-Alcoholic Steatohepatitis.
    Abuobeid R; Herrera-Marcos LV; Arnal C; Bidooki SH; Sánchez-Marco J; Lasheras R; Surra JC; Rodríguez-Yoldi MJ; Martínez-Beamonte R; Osada J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic subcellular distribution of squalene changes according to the experimental setting.
    Martínez-Beamonte R; Alda O; Sanclemente T; Felices MJ; Escusol S; Arnal C; Herrera-Marcos LV; Gascón S; Surra JC; Osada J; Rodríguez-Yoldi MJ
    J Physiol Biochem; 2018 Nov; 74(4):531-538. PubMed ID: 29470816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary squalene modifies plasma lipoproteins and hepatic cholesterol metabolism in rabbits.
    Martínez-Beamonte R; Sánchez-Marco J; Felices MJ; Barranquero C; Gascón S; Arnal C; Burillo JC; Lasheras R; Busto R; Lasunción MA; Rodríguez-Yoldi MJ; Osada J
    Food Funct; 2021 Sep; 12(17):8141-8153. PubMed ID: 34291245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of Biejiajian Pills against non-alcoholic steatohepatitis based on lipidomics].
    Huang J; Wang ML; Zhou ZY; Yan T; Xiong H; Mei ZN
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2557-2565. PubMed ID: 38812156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
    Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
    J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
    Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
    Cells; 2020 May; 9(5):. PubMed ID: 32429478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation.
    Velázquez AM; Roglans N; Bentanachs R; Gené M; Sala-Vila A; Lázaro I; Rodríguez-Morató J; Sánchez RM; Laguna JC; Alegret M
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
    Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
    Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
    J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.
    Rodríguez-Calvo R; Samino S; Girona J; Martínez-Micaelo N; Ràfols P; García-Altares M; Guaita-Esteruelas S; Junza A; Heras M; Yanes O; Correig X; Masana L
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.
    Tran M; Lee SM; Shin DJ; Wang L
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
    Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.